Treatment of Ocular Myasthenia Gravis
Open Access
- 1 January 2019
- journal article
- review article
- Published by Asia Pacific Academy of Ophthalmology in Asia-Pacific Journal of Ophthalmology
- Vol. 7 (4), 257-259
- https://doi.org/10.22608/apo.2018301
Abstract
The Asia-Pacific Journal of Ophthalmology (APJO) is the official publication of the Asia-Pacific Academy of Ophthalmology. The APJO positions itself as a first-class bimonthly (6 issues per year) peer-viewed e-journal representative of ophthalmic and visual science developments in the Asia-Pacific region. The APJO welcomes the submission of original, previously unpublished manuscripts which describe clinical investigations, clinical observations and clinically relevant laboratory investigations.Keywords
This publication has 23 references indexed in Scilit:
- Factors affecting outcome in ocular myasthenia gravisInternational Journal of Neuroscience, 2017
- Does Treatment of Ocular Myasthenia Gravis With Early Immunosuppressive Therapy Prevent Secondarily Generalization and Should It Be Offered to All Such Patients?Journal of Neuro-Ophthalmology, 2016
- Efficacy of prednisone for the treatment of ocular myasthenia (EPITOME): A randomized, controlled trialMuscle & Nerve, 2015
- Prognosis of Ocular Myasthenia GravisOphthalmology, 2015
- EFNS/ENS Guidelines for the treatment of ocular myastheniaEuropean Journal of Neurology, 2014
- Safety of Prednisone for Ocular Myasthenia GravisJournal of Neuro-Ophthalmology, 2012
- Ocular myasthenia gravis: treatment successes and failures in patients with long-term follow-upZeitschrift für Neurologie, 2009
- Mycophenolate mofetil for ocular myastheniaZeitschrift für Neurologie, 2008
- Ocular motor dysfunction and ptosis in ocular myasthenia gravis: effects of treatmentBritish Journal of Ophthalmology, 2005
- Beneficial Effects of Corticosteroids on Ocular Myasthenia GravisArchives of Neurology, 1996